Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru

American Journal of Tropical Medicine and Hygiene

Volumn 72, Issue 5, 2005, Pages 568-572

  Marquiño, Wilmer ^a   Ylquimiche, Laura ^a   Hermenegildo, Ygor ^a   Palacios, Ana Maria ^b   Falconí, Eduardo ^a   Cabezas, César ^a   Arróspide, Nancy ^a   Gutierrez, Sonia ^a   Ruebush II, Trenton K ^c  

^a INSTITUTO NACIONAL DE SALUD   (Peru)

^b MINISTERIO DE SALUD   (Peru)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; FANSIDAR; HEMOGLOBIN; PARACETAMOL; PLASMOTRIN; QUININE; TETRACYCLINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PYRIMETHAMINE; SESQUITERPENE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ADOLESCENT; ADULT; ANOPHELES; ARTICLE; BLOOD SMEAR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PERU; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; CHILD; COMPARATIVE STUDY; DRUG COMBINATION; MALARIA FALCIPARUM;

ARTESUNATE; PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PERU; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE;

EID: 20544450199     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.72.568     Document Type: Article

References (21)

1. White NJ, 1998. Preventing antimalarial drug resistance through combinations. Drug Resist Updates 1: 3-9.
2. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwara G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK II, Danis M, Greenwood BM, Anderson RM, Olliaro P, 1999. Averting a malaria disaster. Lancet 353: 1965-1967.
3. WHO, 1998. The Use of Artemisinin and Its Derivatives as Anti-Malarial Drugs: Report of a Joint CTD/DMP/TDR Informal Consultation. Geneva: World Health Organization. WHO Document WHO/MAL/98.1086
4. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356: 297-302.
5. White NJ, 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41: 1413-1422.
6. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 1654-1658.
7. Doherty F, Sadiq AD, Bayo L, Alloueche A, Olliaro P, Milligan P, von Seidlein L, Pinder M, 1999. A randomized safety and tolerability trial of artresunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg 93: 543-546.
8. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G, 2001. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health 6: 92-98.
9. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett A, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T, 2000. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355: 352-357.
10. Marquiño W, MacArthur JR, Barat LM, Oblitas FE, Arrunátegui M, Garavito G, Chafloque ML, Pardavé B, Gutierrez S, Arrospide N, Carrillo C, Cabezas C, Ruebush TK II, 2003. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Am J Trop Med Hyg 68: 120-123.
11. Ministerio de Salud, Peru, 1999. Politica Nacional de Medicamentos para el Control de la Malaria en el Peru. Lima: MINSA.
12. Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DR, Peters W, 1986. Chemotherapy of Malaria. World Health Organization Monograph Series No. 27, Geneva: World Health Organization.
13. Pan American Health Organization, 1998. Evaluation of the Therapeutic Efficacy of Drugs for the Treatment of Uncomplicated Plasmodium falciparum Malaria in the Americas. Washington, DC: Pan American Health Organization. OPS/HCP/ HCT/113/98.
14. Ministry of Public Health, Thailand, 1996. Post-Registration Surveillance of the Artemisinin Derivatives Used Operationally in Thailand. Nonthaburi, Thailand: Technical Division, Food and Drug Administration.
15. Ribiero IR, Olliaro P, 1998. Safety of artemisinin and its derivatives: a review of published and unpublished clinical trials. Med Trop (Mars) 58: 50-53.
16. Bolero D, Restrepo M, Montoya A, 1985. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria. Bull World Health Organ 3: 731-737.
17. Reyes S, Osanai CH, Costa Passes AD, 1986. Resistência in vivo do Plasmodium falciparum as 4-aminoquinoleínas e á associação sulfadoxina-pirimetamina. II. Estudio de Manaus, Amazonas 1983-1984. Rev Bras Mal Doencas Trop 38: 37-44.
18. Osorio LE, Giraldo LE, Grajales LF, Arriaga AL, Andrade AL, Ruebush TK, Barat LM, 1999. Assessment of the therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in an area of low malaria transmission in Colombia. Am J Trop Med Hyg 61: 968-972.
19. Nwanyanwu OC, Ziba C, Macheso A, Kazembe P, 2000. Efficacy of sulphadoxine-pyrimethamine for acute uncomplicated malaria due to Plasmodium falciparum in Malawian children under five years old. Trop Med Int Health 5: 355-358.
20. White NJ, 1992. Antimalarial drug resistance: the pace quickens. J Antimicrob Agents Chemother 30: 571-585.
21. Watkins WM, Mosobo M, 1993. Treatment of Plasmodium falciparum malaria with PSD: selective pressure for resistance is a function of long elimination half life. Trans R Soc Trop Med Hyg 87: 75-78.